Dexfenfluramine
- Generic Name
- Dexfenfluramine
- Drug Type
- Small Molecule
- Chemical Formula
- C12H16F3N
- CAS Number
- 3239-44-9
- Unique Ingredient Identifier
- E35R3G56OV
Overview
Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.
Background
Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.
Indication
For the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.